Literature DB >> 14598026

Excess mortality after hospitalisation for vertebral fracture.

John A Kanis1, Anders Oden, Olof Johnell, Chris De Laet, Bengt Jonsson.   

Abstract

An excess mortality is well described after vertebral fracture. Deaths are in part related to co-morbidity, but could also be due to the fracture event itself, either directly or indirectly. The aim of this study was to examine the quantum and pattern of mortality following vertebral fracture. We identified 16,051 men and women aged 50 years or more with a vertebral fracture that required hospitalization in 28.8 million person years from the patient register of Sweden. Mortality after vertebral fracture was examined using Poisson models applied to fracture patients and compared to that of the general population. At all ages, the risk of death was markedly increased immediately after the event. After a short period of declining risk, the risk increased with age at a rate that was higher than that of the general population and comparable to that 1 year after hip fracture. The latter function was assumed to be due to deaths related to co-morbidity and the residuum assumed to be due to the vertebral fracture. Causally related deaths comprised 28% of all deaths associated with vertebral fracture (depending on age). We conclude that a minority of deaths following hospitalization for vertebral fracture are attributable to the fracture itself under the assumptions we used.

Entities:  

Mesh:

Year:  2003        PMID: 14598026     DOI: 10.1007/s00198-003-1516-y

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  19 in total

1.  Long-term risk of osteoporotic fracture in Malmö.

Authors:  J A Kanis; O Johnell; A Oden; I Sembo; I Redlund-Johnell; A Dawson; C De Laet; B Jonsson
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

2.  Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group.

Authors:  M C Nevitt; D E Thompson; D M Black; S R Rubin; K Ensrud; A J Yates; S R Cummings
Journal:  Arch Intern Med       Date:  2000-01-10

3.  Mortality after all major types of osteoporotic fracture in men and women: an observational study.

Authors:  J R Center; T V Nguyen; D Schneider; P N Sambrook; J A Eisman
Journal:  Lancet       Date:  1999-03-13       Impact factor: 79.321

4.  Risk of mortality following clinical fractures.

Authors:  J A Cauley; D E Thompson; K C Ensrud; J C Scott; D Black
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

5.  Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group.

Authors:  D M Kado; W S Browner; L Palermo; M C Nevitt; H K Genant; S R Cummings
Journal:  Arch Intern Med       Date:  1999-06-14

6.  Consequences of a hip fracture: a prospective study over 1 year.

Authors:  I Sernbo; O Johnell
Journal:  Osteoporos Int       Date:  1993-05       Impact factor: 4.507

7.  Bone mineral density is a predictor of survival.

Authors:  C Johansson; D Black; O Johnell; A Odén; D Mellström
Journal:  Calcif Tissue Int       Date:  1998-09       Impact factor: 4.333

8.  Population-based study of survival after osteoporotic fractures.

Authors:  C Cooper; E J Atkinson; S J Jacobsen; W M O'Fallon; L J Melton
Journal:  Am J Epidemiol       Date:  1993-05-01       Impact factor: 4.897

9.  The components of excess mortality after hip fracture.

Authors:  J A Kanis; A Oden; O Johnell; C De Laet; B Jonsson; A K Oglesby
Journal:  Bone       Date:  2003-05       Impact factor: 4.398

10.  Mortality following fractures in older women. The study of osteoporotic fractures.

Authors:  W S Browner; A R Pressman; M C Nevitt; S R Cummings
Journal:  Arch Intern Med       Date:  1996-07-22
View more
  86 in total

1.  Hospitalised osteoporotic vertebral fractures in Spain: analysis of the national hospital discharge registry.

Authors:  C Bouza; T López; M Palma; J M Amate
Journal:  Osteoporos Int       Date:  2007-01-13       Impact factor: 4.507

2.  Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden: an economic evaluation based on the MORE study.

Authors:  Fredrik Borgström; Olof Johnell; John A Kanis; Anders Oden; David Sykes; Bengt Jönsson
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

3.  Determinants of health-related quality of life in women with vertebral fractures.

Authors:  Alexandra Papaioannou; Courtney C Kennedy; George Ioannidis; Jacques P Brown; Anjali Pathak; David A Hanley; Robert G Josse; Rolf J Sebaldt; Wojciech P Olszynski; Alan Tenenhouse; Timothy M Murray; Annie Petrie; Charles H Goldsmith; Jonathan D Adachi
Journal:  Osteoporos Int       Date:  2005-12-09       Impact factor: 4.507

4.  Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm.

Authors:  K Kim; A Svedbom; X Luo; S Sutradhar; J A Kanis
Journal:  Osteoporos Int       Date:  2013-10-10       Impact factor: 4.507

5.  Quality of life, morbidity, and mortality after low trauma hip fracture in men.

Authors:  I Pande; D L Scott; T W O'Neill; C Pritchard; A D Woolf; M J Davis
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

6.  Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis.

Authors:  O Ström; B Jönsson; J A Kanis
Journal:  Osteoporos Int       Date:  2012-12-07       Impact factor: 4.507

Review 7.  Fracture mortality: associations with epidemiology and osteoporosis treatment.

Authors:  Sebastian E Sattui; Kenneth G Saag
Journal:  Nat Rev Endocrinol       Date:  2014-08-05       Impact factor: 43.330

8.  Thoracolumbar vertebral fractures in Sweden: an analysis of 13,496 patients admitted to hospital.

Authors:  Karl-Ake Jansson; Paul Blomqvist; Per Svedmark; Fredrik Granath; Erik Buskens; Martin Larsson; Johanna Adami
Journal:  Eur J Epidemiol       Date:  2010-05-07       Impact factor: 8.082

9.  Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden.

Authors:  John A Kanis; Olof Johnell; Anders Oden; Frederik Borgstrom; Helena Johansson; Chris De Laet; Bengt Jönsson
Journal:  Osteoporos Int       Date:  2004-04-22       Impact factor: 4.507

Review 10.  Patient preference in the management of postmenopausal osteoporosis with bisphosphonates.

Authors:  Jean-Yves Reginster; Véronique Rabenda
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.